Korean firms shy of R&D

Korean drug firms are showing a negative attitude towards research and development (R&D) due to the government’s plan to cut drug prices by an average of 17 percent starting next year, according to Rep. Choi Young-hee of the main opposition Democratic Party who commissioned the survey with the Korea Drug Research Association.

According to a survey of 20 pharmaceutical companies, conducted fr...